Uterine fibroids are benign smooth muscle tumors of the uterus, causing heavy menstrual bleeding, pelvic pressure, and urinary symptoms. They affect up to 70% of women by age 50; treatment ranges from watchful waiting to medication or surgical removal.
Reproductive and gynaecological conditions generate complications through hormonal dysregulation, structural pathology, fertility impairment, and the downstream consequences of chronic inflammation or surgical intervention. Endometriosis exemplifies progressive organ damage through adhesion formation, ovarian reserve depletion, and bowel/bladder involvement. Polycystic ovary syndrome carries metabolic consequences beyond fertility — insulin resistance, cardiovascular risk, and endometrial cancer risk from unopposed oestrogen. Gestational complications can be acutely life-threatening for both mother and fetus.
Immediate clinical action required
The following signs may indicate a new or worsening complication requiring prompt clinical evaluation:
Treatment & Management
Evidence-based treatment pathway, medications, and escalation criteria
Prognosis & Outlook
Long-term clinical outlook, improving and worsening outcome factors
Differential Diagnosis
Conditions that mimic Uterine Fibroids — distinguishing features & tests
Uterine Fibroids Overview
Symptoms, causes, and general condition overview
These conditions share overlapping symptoms with Uterine Fibroids but have distinct complication patterns — understanding the differences is clinically important.
Describe your symptoms and get a structured clinical assessment — possible causes, red flags, and recommended next steps.
Start Free AI Analysis →Content on this page is informed by evidence-based clinical sources including: